Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP419614.RA5QGlLEVQP806Zkv0UbYF4m5rgRiy8EA8i5S9L3Vnm3s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP419614.RA5QGlLEVQP806Zkv0UbYF4m5rgRiy8EA8i5S9L3Vnm3s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP419614.RA5QGlLEVQP806Zkv0UbYF4m5rgRiy8EA8i5S9L3Vnm3s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP419614.RA5QGlLEVQP806Zkv0UbYF4m5rgRiy8EA8i5S9L3Vnm3s130_provenance.
- NP419614.RA5QGlLEVQP806Zkv0UbYF4m5rgRiy8EA8i5S9L3Vnm3s130_assertion description "[Semi-quantitative RT-PCR, Western blotting and immunohistochemistry indicate that leiomyoma and myometrium expresses receptor-activated Smad3, common Smad4 and inhibitory Smad7, with elevated expression of Smad3, Smad4 and phosphorylated Smad3 (pSmad3) as well as TGF-betaR type I and type II in leiomyoma compared to myometrium (P<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419614.RA5QGlLEVQP806Zkv0UbYF4m5rgRiy8EA8i5S9L3Vnm3s130_provenance.
- NP419614.RA5QGlLEVQP806Zkv0UbYF4m5rgRiy8EA8i5S9L3Vnm3s130_assertion evidence source_evidence_literature NP419614.RA5QGlLEVQP806Zkv0UbYF4m5rgRiy8EA8i5S9L3Vnm3s130_provenance.
- NP419614.RA5QGlLEVQP806Zkv0UbYF4m5rgRiy8EA8i5S9L3Vnm3s130_assertion SIO_000772 14604812 NP419614.RA5QGlLEVQP806Zkv0UbYF4m5rgRiy8EA8i5S9L3Vnm3s130_provenance.
- NP419614.RA5QGlLEVQP806Zkv0UbYF4m5rgRiy8EA8i5S9L3Vnm3s130_assertion wasDerivedFrom befree-2016 NP419614.RA5QGlLEVQP806Zkv0UbYF4m5rgRiy8EA8i5S9L3Vnm3s130_provenance.
- NP419614.RA5QGlLEVQP806Zkv0UbYF4m5rgRiy8EA8i5S9L3Vnm3s130_assertion wasGeneratedBy ECO_0000203 NP419614.RA5QGlLEVQP806Zkv0UbYF4m5rgRiy8EA8i5S9L3Vnm3s130_provenance.
- befree-2016 importedOn "2016-02-19" NP419614.RA5QGlLEVQP806Zkv0UbYF4m5rgRiy8EA8i5S9L3Vnm3s130_provenance.